You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 2, February 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  Head and Neck Society News
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Cutting Edge

GEORGE A. SISSON, SR, MD
Northwestern University Medical School, Chicago

SHAN R. BAKER, MD
Ann Arbor, Mich

Arch Otolaryngol Head Neck Surg. 1989;115(2):149.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In an effort to improve palliation and, perhaps, even cure of patients with persistent or recurrent squamous cell carcinoma of the head and neck after irradiation and surgery or chemotherapy, researchers at Memorial Medical Center of Long Beach (Calif) have treated such patients with interstitial hyperthermia concomitant with interstitial irradiation (thermoendocurie therapy). A. A. Puthawala and coworkers reported their initial experience with this approach at the Second International Head and Neck Oncology Research Conference. Forty-four patients with a biopsy-proven diagnosis of recurrent and/or persistent squamous cell carcinoma of the head and neck received thermoendocurie therapy for salvage. All patients had previously either undergone a course of external irradiation to doses of 66 to 80 Gy as a definitive treatment, or had received preoperative or postoperative treatment to doses of 50 to 60 Gy. The majority of these patients had also received systemic chemotherapy.

The treatment modality consisted of two interstitial . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.